Source: cancertreatmentmx.com Author: staff UCLA scientists have come up with a revolutionary new way of identifying oral cancer. Funded by the National Institute of Dental and Cranial Facial Research, they developed a simple saliva test that makes detecting oral cancer easy. No longer must patients wait until they find an unusual sore in their mouth [...]
Continue reading...Sunday, February 12, 2012
Source: www.oncologyreport.com/ AUthor: Miriam E. Tucker Intensity-modulated radiotherapy is more expensive than 3-D–conformal radiotherapy is and has not been shown to improve standard outcomes in patients with head and neck cancer. But it results in better quality of life. These findings from two studies presented at the Multidisciplinary Head and Neck Cancer Symposium raise the [...]
Continue reading...Wednesday, February 1, 2012
Source: University of Minnesota It’s a researcher’s dream: a simple, noninvasive test to detect life-threatening cancer, heart disease, or other maladies while they’re still treatable. A team of University of Minnesota researchers is in hot pursuit of that goal, using one of the simplest means imaginable: testing spit. They’ve discovered that conditions such as breast [...]
Continue reading...Tuesday, January 10, 2012
Source: www.thetelegraphandargus.co.uk/ Author: staff Mouth cancer patients in Bradford will be the first in the world to try a new battery-powered gum shield that could end the misery of a dry mouth. The pacemaker device fits over the lower teeth and uses minor, painless, electric shocks to trigger saliva production. A dry mouth is a [...]
Continue reading...Thursday, December 22, 2011
Source: www.proactiveinvestors.com Author: Amanda Brandon Vigilant Biosciences is a privately held medical technology company based in Norcross, Georgia focused on improving healthcare products to improve patient care. Their most recent research efforts center on early oral cancer detection. In the United States, approximately 37,000 people will be diagnosed with oral cancer this year and its [...]
Continue reading...Thursday, December 22, 2011
Soure: www.curetoday.com/ Author: Lacey Meyer Dentists advise resolving tooth and gum issues before starting cancer treatment. Bettye Davis admits she has never had very good teeth. But when she received a diagnosis of salivary gland cancer, she was surprised that her oncologist recommended she visit a dentist before beginning radiation treatments to her jaw. “When [...]
Continue reading...Sunday, November 6, 2011
Source: http://www.sciencenews.org Author: Susan Galdos Rinse and spit. Someday soon, doctors may join dentists in issuing these simple instructions. And before leaving the office, you might know whether you’re at risk for oral cancer. Additional tests on that same ptui may reveal whether you show signs of certain other cancers or diseases such as diabetes [...]
Continue reading...Friday, September 2, 2011
Source: www.healthnewsdigest.com Author: press release Researchers at The Ohio State University Comprehensive Cancer Center have developed a medicated oral patch that allows a chemoprevention drug to release directly into precancerous lesions in the mouth over an extended time. The study evaluated the drug fenretinide, a synthetic derivative of vitamin A that has highly promising anti-cancer [...]
Continue reading...Friday, February 4, 2011
Source: www.thelancet.com Authors: Dr Christopher M Nutting FRCR et al. Background: Xerostomia is the most common late side-effect of radiotherapy to the head and neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) can reduce irradiation of the parotid glands. We assessed the hypothesis that parotid-sparing IMRT reduces the incidence of severe xerostomia. Methods: We undertook [...]
Continue reading...Thursday, January 13, 2011
Source: jjco.oxfordjournals.org Authors: Etsushi Tomitaka et al. Objective: To evaluate longitudinal changes in parotid volumes and saliva production over 2 years after 30 Gy irradiation. Methods: We retrospectively evaluated 15 assessable patients treated for advanced oral cancer. Eligibility criteria were a pathologic diagnosis of squamous cell carcinoma, preoperative radiation therapy with a total dose of [...]
Continue reading...
Tuesday, April 3, 2012
0 Comments